This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (38)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Atypical Manifestations Suggesting an Immunologic Disease

WILLIAM DAMESHEK, M.D.; HUGH FUDENBERG, M.D.

AMA Arch Intern Med. 1957;99(2):202-208.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hemolytic disease of insidious onset and chronic course, characterized by an intracorpuscular erythrocytic defect rendering the cells unusually susceptible to hemolysis in vitro and probably in vivo upon slight acidification of the plasma. The constant feature of the disease is hemosiderinuria, rather than hemoglobinuria¹; in some cases hemoglobinuria may occur rarely or not at all.^2-5 Although an excellent account of this syndrome was provided by Striibing, in 1882,⁶ only 38 cases had been recorded by 1937.⁷ Crosby's classic monograph in 1953 analyzed the clinical and laboratory features of 162 collected cases.⁸ Since then, many typical cases have been readily recognized by their clinical features, with subsequent laboratory confirmation by the Ham acid-hemolysis test,⁹ and 18 additional cases have been reported.^10,23

The atypical clinical and serologic features of the following three cases rendered diagnosis difficult and merit mention. Two of these cases presented with . . . [Full Text PDF of this Article]

Author Affiliations
Boston

From the Blood Research Laboratory, a unit of the Ziskind Laboratories, of the New England Center Hospital, and the Department of Medicine, Tufts University School of Medicine.

Footnotes
Submitted for publication July 5, 1956.

Public Health Service Research Fellow of the National Heart Institute (Dr. Fudenberg).

Aided by Grants-in-Aid from the American Cancer Society (CPB-16F) and the Public Health Service, National Institute of Arthritis and Metabolic Diseases (A-554).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?